Jaye Thompson's Insider Trades & SAST Disclosures
Jaye Thompson's most recent trade in Greenwich LifeSciences Inc was a trade of 149,818 Stock Options done . Disclosure was reported to the exchange on Dec. 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jaye Thompson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Dec 2024 | 149,818 | 299,636 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.91 per share. | 21 Nov 2024 | 1,000 | 264,148 | - | 12.9 | 12,910 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 13.85 per share. | 12 Aug 2024 | 800 | 263,148 | - | 13.9 | 11,080 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 15.15 per share. | 02 Aug 2024 | 1,000 | 262,348 | - | 15.2 | 15,150 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 18 Jul 2024 | 1,000 | 261,348 | - | 16 | 16,000 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 9.49 per share. | 13 Jul 2023 | 250 | 259,248 | - | 9.5 | 2,373 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 11.22 per share. | 28 Apr 2023 | 250 | 258,998 | - | 11.2 | 2,805 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 11.87 per share. | 11 Apr 2023 | 1,000 | 258,745 | - | 11.9 | 11,870 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.71 per share. | 15 Mar 2023 | 250 | 257,745 | - | 12.7 | 3,178 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 15.40 per share. | 24 Feb 2023 | 250 | 257,495 | - | 15.4 | 3,849 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 20.84 per share. | 03 Feb 2023 | 250 | 257,245 | - | 20.8 | 5,210 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 19.20 per share. | 27 Jan 2023 | 250 | 256,995 | - | 19.2 | 4,800 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.50 per share. | 13 Jan 2023 | 250 | 256,745 | - | 16.5 | 4,125 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 12.94 per share. | 16 Dec 2022 | 250 | 256,495 | - | 12.9 | 3,235 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 13.98 per share. | 02 Dec 2022 | 250 | 256,245 | - | 14.0 | 3,495 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 149,818 | 149,818 | - | - | Stock Options | |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.74 per share. | 19 Apr 2022 | 500 | 255,995 | - | 16.7 | 8,370 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 18.47 per share. | 31 Jan 2022 | 500 | 255,495 | - | 18.5 | 9,235 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg Affairs | Purchase of securities on an exchange or from another person at price $ 16.33 per share. | 21 Jan 2022 | 500 | 254,995 | - | 16.3 | 8,165 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg. Affairs | Purchase of securities on an exchange or from another person at price $ 18.87 per share. | 18 Jan 2022 | 500 | 254,495 | - | 18.9 | 9,435 | Common Stock |
| Greenwich LifeSciences Inc | Jaye Thompson | VP Clinical Reg. Affairs | Purchase of securities on an exchange or from another person at price $ 19.99 per share. | 13 Jan 2022 | 1,000 | 253,995 | - | 20.0 | 19,990 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges